Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 6,130 | reported | 03 Mar 2025 | tx 122+1,350,542−1,097,843 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 16,904 | 205.02 USD | |
| 03 Mar 2025 | SALE | AbbVie Inc. | 5,677 | 209.80 USD | |
| 03 Mar 2025 | SALE | AbbVie Inc. | 14,973 | 210.66 USD | |
| 03 Mar 2025 | SALE | AbbVie Inc. | 600 | 211.32 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 13,073 | 202.92 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 4,308 | 201.97 USD | |
| 26 Feb 2025 | EXERCISE | AbbVie Inc. | 22,210 | 114.36 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 1,526 | 203.64 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 4,781 | 202.93 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 1,400 | 202.06 USD | |
| 26 Feb 2025 | SALE | AbbVie Inc. | 4,829 | 203.63 USD | |
| 26 Feb 2025 | EXERCISE | AbbVie Inc. | 22,210 | 114.36 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 17,986 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 6,998 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 5,792 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 7,378 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 22,916 | 0.00 USD | deriv |
| 01 Mar 2024 | EXERCISE | AbbVie Inc. | 45,700 | 61.36 USD | |
| 01 Mar 2024 | SALE | AbbVie Inc. | 30,288 | 177.71 USD | |
| 01 Mar 2024 | SALE | AbbVie Inc. | 20,127 | 177.71 USD | |
| 01 Mar 2024 | SALE | AbbVie Inc. | 15,412 | 176.40 USD | |
| 01 Mar 2024 | SALE | AbbVie Inc. | 9,853 | 176.35 USD | |
| 01 Mar 2024 | EXERCISE | AbbVie Inc. | 45,700 | 61.36 USD | deriv |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 23,847 | 178.99 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 32,097 | 0.00 USD |